Purchase Order 75N95020P00751
- Not listed
- This contract award to Life Technologies Corporation, a division of Thermo Fisher Scientific, was made by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse. The $294,889 firm-fixed-price purchase order is for the delivery of a specialized 7-channel fluorescent imaging instrument with automated plate handling and high-content screening software. The equipment will support NIH's mission of medical research and applications to...
- This federal contract award to Life Technologies Corporation, doing business as Thermo Fisher Scientific, is for the provision of drugs and biologicals. The contract is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call with the National Institutes of Health (NIH), a civilian agency, and has a ceiling value of $15,131.50. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. The contract covers the delivery of real-time PCR...
- This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) to Life Technologies Corporation (doing business as Thermo Fisher Scientific) for the provision of laboratory equipment, reagents, assays, and associated repair services to support biomedical research, medical readiness, and forensic analysis initiatives across multiple federal agencies. The $3,032.40 contract has an ultimate completion date of August 15, 2013 and does not utilize a set-aside designation....
- Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $18,232.42 firm fixed-price purchase order by the NIH Clinical Center on September 3, 2025, for the delivery of laboratory equipment including an E-Gel Power Snap Plus Electrophoresis System, Qubit 4 Fluorometer, and Veritipro Thermal instrument. The contract carries an ultimate completion date of October 3, 2025, and the place of performance is Carlsbad, California. No set-aside designation was applied to...
- Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., was awarded a $94,710.82 firm fixed-price purchase order by a civilian federal agency under the Pacific West Area on April 4, 2017, for a flow cytometer system. The contract, which required completion by April 29, 2017, represents a non-set-aside procurement reflecting Life Technologies' specialized technological capabilities in biomedical research instrumentation. The place of performance is Grand Island, New York,...
- Life Technologies Corporation, operating as Thermo Fisher Scientific, received a $80,000 firm fixed price purchase order from the National Institute of Allergy and Infectious Diseases (NIAID) on July 26, 2021, with an ultimate completion date of July 26, 2022. The contract award was issued to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a), in preparation for the September 30, 2026 closing of the period of availability...
- This federal contract award is for the supply of a flow cytometer instrument to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency under the National Institutes of Health. The $350,000.00 firm-fixed-price purchase order was awarded to Life Technologies Corporation, doing business as Thermo Fisher Scientific, a prominent manufacturer of scientific instruments and biotechnology products that serves as a prime contractor for various federal agencies. The...
- Life Technologies Corporation, operating as Thermo Fisher Scientific, received a Firm Fixed Price Blanket Purchase Agreement (BPA) call award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) on December 1, 2024, with a ceiling value of $24,309.72. This maintenance agreement covers support for an Attune NXT Flow Cytometer and CyTEK Max equipment and represents part of the FY26 Unconstrained Discretionary Obligation (UDO) Initiative. The work is scheduled...
- This firm-fixed-price contract was awarded to Life Technologies Corporation, doing business as Thermo Fisher Scientific, for warranty and preventative maintenance services on QuantStudio 12K instruments. The $13,414.35 contract was awarded by the National Institute on Drug Abuse, a civilian federal agency, on September 10, 2020 with a completion date of September 9, 2021. This contract award is not associated with a set-aside program. Life Technologies Corporation is a prominent manufacturer...
- This $2,728.80 firm fixed-price purchase order was awarded by the National Institute of Neurological Disorders and Stroke, a civilian agency, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for the repair of an ultracentrifuge instrument. The proper operation of this instrument is necessary to process critical and irreplaceable samples that would otherwise be lost. The award has an ultimate completion date of June 30, 2025 and was made without the use of a...
Life Technologies Corporation, doing business as Thermo Fisher Scientific, was awarded a $476,157.04 firm fixed-price purchase order by the National Institute on Drug Abuse on September 25, 2020, for a flow cytometry system. The contract, which carries no set-aside designation, fulfills a solicitation issued by the National Institutes of Health National Institute on Neurological Disorders and Stroke. The equipment specified includes a 12-channel imaging cytometer equipped with 7 excitation lasers across the ultraviolet-near infrared spectrum and integrated image analysis software. Performance of this equipment delivery and installation was to occur at the agency's facility in Bethesda, Maryland, with delivery and installation required within 30 days of award. The procurement was evaluated on a lowest-priced technically acceptable basis using commercial item standards, with consideration given to pricing, warranty information, and the vendor's ability to meet specified technical requirements. This award represents a de-obligation action related to fiscal year 2020 funding, with an ultimate completion date of October 16, 2025, executed in accordance with 31 U.S.C. Section 1552(a) to administratively de-obligate expiring fiscal year funds in preparation for the September 30, 2025 closing of the period of availability. Life Technologies Corporation, a prominent manufacturer of scientific instruments and biotechnology products, has established itself as a key federal supplier across multiple agencies including the National Institutes of Health, Department of Defense, and the Centers for Disease Control and Prevention, providing laboratory equipment, genetic analysis technologies, and technical support services that enable advanced research and operational capabilities.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Flow Cytometry System | 75N95020Q00316 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Award Notice 2/2 | 9/28/20, 3:02 PM | |
Flow Cytometry System | 75N95020Q00316 | Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse | Solicitation 1/2 | 9/10/20, 3:26 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Funding Only Action | ($5k) | 9/16/25 | |
| P00002 | Funding Only Action | ($5k) | 9/12/25 | |
| P00001 | Supplemental Agreement for work within scope | $0 | 3/4/22 | |
| Not listed | Not listed | $486.1k | 9/25/20 |